Success Stories
Highlights of the PCI news focused on Penn commercialization accomplishments
COVID-19 mRNA vaccine that uses fundamental Penn technology receives FDA approval
The U.S. FDA has given the first full approval to a COVID-19 mRNA vaccine, which uses modified mRNA technology invented and developed by scientists at Penn.
Penn I-Corps completed two successful cohorts during FY21 with 22 different teams
A look at I-Corps in FY21
PCI and Pennovation Center sponsor Philly Tech Week and PACT Capital Conference
Along with the Penn Emerging Startup pitch session, PCI and the Pennovation Center sponsored Philly Tech Week with financial and marketing support.
PCI programming goes virtual
Throughout FY21, the PCI full suite of programming from I-Corps and Fellows training to our speaker series, were hosted entirely online.
Neuralert achieves a key milestone
Neuralert is developing a novel invention that addresses the problem of late or undetected stroke in hospitalized patients.
Verismo launches with CAR-T expert co-founders
Verismo, a new cell therapy company pioneering multi-chain CAR-T technology, raised $16 million in equity financing.
G2Bio launches with $200M to invest in research and development of novel gene therapies
The G2 Bio Companies, founded by James M. Wilson and the late Tachi Yamada, launched with a $200 million investment commitment from the global investment firm Temasek.